SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment

Never Miss a Story

Sign up for email alerts

 

More Industry Headlines

Hackers stole data from 4.5 million patients Data security breaches are a big issue in U.S.

GE Healthcare Life Sciences moves to Massachusetts $21-million-dollar facility to open in the spring

New imaging system monitors treatment in real time Improves quality of life and life span for cystic fibrosis patients

People want dementia diagnosed despite no cure New GE research shows worldwide consensus

ECRI founder and emeritus president passes away Dr. Joel Nobel dies at 79

Technique improves treatment of Alzheimer's and Parkinson's Uses acoustic pressure from ultrasound

Siemens' new CT algorithm gets FDA nod Improves reconstructed image quality

NorthStar will supply GE with Mo-99 Only U.S. domestic supply

Home infusion pump market is set to grow Expected to reach $26.7 billion by 2020

Intel and MJFF team up for Parkinson's disease Leveraging wearable devices and big data

After testicular cancer, follow-up CT scans don't up tumor risk

by Brendon Nafziger , DOTmed News Associate Editor
Follow-up CT scans for men previously diagnosed with testicular cancer don't appear to up the risk for new tumors, according to a new study.

The study, published Monday online ahead of print in the Journal of Clinical Oncology, tracked thousands of patients, some for nearly a decade.

Story Continues Below Advertisement

OiHealthcare - ISO 9001 & 13485 Certified - Call 888-673-5151

Oxford Instruments Healthcare, is a leading ISO 9001 & 13485-certified organization, that specializes in providing quality after-market GE CT and MRI systems, service and parts - at prices you can afford.



Men previously treated for low-grade testicular cancer often have abdominal-pelvic CT scans to monitor for recurring disease. But doctors have long wondered if the ionizing radiation delivered from the scans affect patients' future cancer risk.

Yet in their recent study, a group of Canadian scientists say the scans appear to be safe.

"Second malignancies of the abdomen-pelvis are uncommon in men with low-grade testicular cancer," wrote the researchers, led by Dr. Carl van Walraven of the University of Ottawa. "In this study, the risk of second cancer was not associated with the amount of diagnostic radiation exposure."

The researchers said they used population-based datasets to find every testicular cancer patient in Ontario from 1991 to 2004, excluding only those who had radiation therapy, a previous cancer, retroperitoneal lymph node dissection or were under observation for less than 5 years. Radiation therapy, which uses much higher doses of radiation than CT scans, is linked with cancer recurrence.

The remaining 2,569 men (average age: 35) were observed for a median 11 years -- in general, until the end of 2009, or until they developed a second abdominal-pelvic cancer or died.

These men underwent a median 10 CT scans within the first 5 years of testicular cancer diagnosis, receiving a median radiation exposure of 110 mSv from the scans. Nonetheless, the scans weren't linked with developing a secondary malignancy.

About 14 men -- for a rate of five per 10,000 patients-years of observation -- developed a second tumor, the researchers said, most commonly a colorectal or kidney malignancy.

Related:


Interested in Medical Industry News? Subscribe to DOTmed's weekly news email and always be informed. Click here, it takes just 30 seconds.

You Must Be Logged In To Post A Comment

Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2014 DOTmed.com, Inc.
ALL RIGHTS RESERVED